Gare K, Sebakeng M, Molefi M
BMC Infect Dis. 2024; 24(1):1367.
PMID: 39614181
PMC: 11606066.
DOI: 10.1186/s12879-024-10258-7.
Bansal N, Arunachala S, Ullah M, Kulkarni S, Ravindran S, ShankaraSetty R
J Clin Med. 2024; 13(14).
PMID: 39064155
PMC: 11278349.
DOI: 10.3390/jcm13144115.
Inbaraj L, Manesh A, Ponnuraja C, Bhaskar A, Srinivasalu V, Daniel B
Trials. 2024; 25(1):294.
PMID: 38693583
PMC: 11064413.
DOI: 10.1186/s13063-024-08133-6.
Mainga T, Schaap A, Scherer N, Mactaggart I, Shanaube K, Ayles H
Glob Ment Health (Camb). 2024; 10:e89.
PMID: 38161750
PMC: 10755383.
DOI: 10.1017/gmh.2023.83.
Nightingale R, Carlin F, Meghji J, McMullen K, Evans D, van der Zalm M
Int J Tuberc Lung Dis. 2023; 27(4):248-283.
PMID: 37035971
PMC: 10094053.
DOI: 10.5588/ijtld.22.0514.
Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: A systematic review and meta-analysis.
Maleche-Obimbo E, Odhiambo M, Njeri L, Mburu M, Jaoko W, Were F
PLOS Glob Public Health. 2023; 2(12):e0000805.
PMID: 36962784
PMC: 10021795.
DOI: 10.1371/journal.pgph.0000805.
Quality of Life Amongst Multidrug-Resistant TB Patients: An Exploratory Study About Distributive Dimensions and Interactions.
Sharma S, Krishna N S, Kokane A, Pakhare A, Nawaz M, Joshi A
Cureus. 2022; 14(9):e29389.
PMID: 36304356
PMC: 9585424.
DOI: 10.7759/cureus.29389.
TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban Malawi.
Tomeny E, Nightingale R, Chinoko B, Nikolaidis G, Madan J, Worrall E
BMJ Glob Health. 2022; 7(5).
PMID: 35606014
PMC: 9125716.
DOI: 10.1136/bmjgh-2021-007643.
Prospective Evaluation of Positivity Rates of -Specific IgG and Quality of Life in HIV-Negative Tuberculosis Patients in Lagos, Nigeria.
Oladele R, Gbajabimiala T, Irurhe N, Skevington S, Denning D
Front Cell Infect Microbiol. 2022; 12:790134.
PMID: 35186788
PMC: 8851390.
DOI: 10.3389/fcimb.2022.790134.
Bayesian structural equation modeling for post treatment health related quality of life among tuberculosis patients.
Vasantha M, Muniyandi M, Ponnuraja C, Srinivasan R, Venkatesan P
PLoS One. 2021; 16(5):e0252205.
PMID: 34048437
PMC: 8162623.
DOI: 10.1371/journal.pone.0252205.
Quality of life, tuberculosis and treatment outcome; a case-control and nested cohort study.
Datta S, Gilman R, Montoya R, Quevedo Cruz L, Valencia T, Huff D
Eur Respir J. 2020; 56(2).
PMID: 32366485
PMC: 7406858.
DOI: 10.1183/13993003.00495-2019.
Quality of life with tuberculosis.
Aggarwal A
J Clin Tuberc Other Mycobact Dis. 2019; 17:100121.
PMID: 31788563
PMC: 6880022.
DOI: 10.1016/j.jctube.2019.100121.
The Effect of Treatment during A Haze/Post-Haze Year on Subsequent Respiratory Morbidity Status among Successful Treatment Tuberculosis Cases.
Suyanto S, Geater A, Chongsuvivatwong V
Int J Environ Res Public Health. 2019; 16(23).
PMID: 31771136
PMC: 6926855.
DOI: 10.3390/ijerph16234669.
Health-related quality of life of patients with multidrug-resistant tuberculosis in Yemen: prospective study.
Jaber A, Ibrahim B
Health Qual Life Outcomes. 2019; 17(1):142.
PMID: 31420045
PMC: 6698009.
DOI: 10.1186/s12955-019-1211-0.
The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa.
Sineke T, Evans D, Schnippel K, van Aswegen H, Berhanu R, Musakwa N
Health Qual Life Outcomes. 2019; 17(1):94.
PMID: 31151398
PMC: 6545023.
DOI: 10.1186/s12955-019-1155-4.
Impairment of Health-related Quality of Life among Indian Patients with Hypothyroidism.
Shivaprasad C, Rakesh B, Anish K, Annie P, Amit G, Dwarakanath C
Indian J Endocrinol Metab. 2018; 22(3):335-338.
PMID: 30090724
PMC: 6063179.
DOI: 10.4103/ijem.IJEM_702_17.
Sequelae of pulmonary multidrug-resistant tuberculosis at the completion of treatment.
Singla R, Mallick M, Mrigpuri P, Singla N, Gupta A
Lung India. 2018; 35(1):4-8.
PMID: 29319026
PMC: 5760866.
DOI: 10.4103/lungindia.lungindia_269_16.
Evaluation of health-related quality of life in patients with tuberculosis who completed treatment in Kiribati.
Li C, Chu K, Reiher B, Kienene T, Chien L
J Int Med Res. 2017; 45(2):610-620.
PMID: 28415942
PMC: 5536668.
DOI: 10.1177/0300060517694491.
Factors Influencing Quality of Life and Predictors of Low Quality of Life Scores in Patients on Treatment for Pulmonary Tuberculosis: A Cross Sectional Study.
Adeyeye O, Ogunleye O, Coker A, Kuyinu Y, Bamisile R, Ekrikpo U
J Public Health Afr. 2017; 5(2):366.
PMID: 28299129
PMC: 5345416.
DOI: 10.4081/jphia.2014.366.
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.
Sagwa E, Ruswa N, Mavhunga F, Rennie T, Leufkens H, Mantel-Teeuwisse A
Patient Prefer Adherence. 2016; 10:2369-2377.
PMID: 27920503
PMC: 5125758.
DOI: 10.2147/PPA.S116860.